These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37635751)

  • 1. Spotlight on GOT2 in Cancer Metabolism.
    Kerk SA; Garcia-Bermudez J; Birsoy K; Sherman MH; Shah YM; Lyssiotis CA
    Onco Targets Ther; 2023; 16():695-702. PubMed ID: 37635751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context.
    Kerk SA; Lin L; Myers AL; Sutton DJ; Andren A; Sajjakulnukit P; Zhang L; Zhang Y; Jiménez JA; Nelson BS; Chen B; Robinson A; Thurston G; Kemp SB; Steele NG; Hoffman MT; Wen HJ; Long D; Ackenhusen SE; Ramos J; Gao X; Nwosu ZC; Galban S; Halbrook CJ; Lombard DB; Piwnica-Worms DR; Ying H; Pasca di Magliano M; Crawford HC; Shah YM; Lyssiotis CA
    Elife; 2022 Jul; 11():. PubMed ID: 35815941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition.
    Yang S; Hwang S; Kim M; Seo SB; Lee JH; Jeong SM
    Cell Death Dis; 2018 Jan; 9(2):55. PubMed ID: 29352139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cancer Cell-Intrinsic GOT2-PPARδ Axis Suppresses Antitumor Immunity.
    Abrego J; Sanford-Crane H; Oon C; Xiao X; Betts CB; Sun D; Nagarajan S; Diaz L; Sandborg H; Bhattacharyya S; Xia Z; Coussens LM; Tontonoz P; Sherman MH
    Cancer Discov; 2022 Oct; 12(10):2414-2433. PubMed ID: 35894778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLS and GOT2 as prognostic biomarkers associated with dendritic cell and immunotherapy response in breast cancer.
    Yang R; Cheng S; Xiao J; Pei Y; Zhu Z; Zhang J; Feng J; Li J
    Heliyon; 2024 Jan; 10(1):e24163. PubMed ID: 38234908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glutamate oxaloacetate transaminase on reactive oxygen species in Ganoderma lucidum.
    Liu H; Qiao J; Shangguan J; Zhu J
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1845-1861. PubMed ID: 36754884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation.
    Hong R; Zhang W; Xia X; Zhang K; Wang Y; Wu M; Fan J; Li J; Xia W; Xu F; Chen J; Wang S; Zhan Q
    Mol Oncol; 2019 Apr; 13(4):959-977. PubMed ID: 30714292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.
    Yang H; Zhou L; Shi Q; Zhao Y; Lin H; Zhang M; Zhao S; Yang Y; Ling ZQ; Guan KL; Xiong Y; Ye D
    EMBO J; 2015 Apr; 34(8):1110-25. PubMed ID: 25755250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors.
    Li Y; Li B; Xu Y; Qian L; Xu T; Meng G; Li H; Wang Y; Zhang L; Jiang X; Liu Q; Xie Y; Cheng C; Sun B; Yu D
    Cancer Res; 2022 Sep; 82(18):3223-3235. PubMed ID: 35895805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of
    Ferreira WAS; de Oliveira EHC
    Curr Issues Mol Biol; 2022 May; 44(6):2472-2489. PubMed ID: 35735610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GOT2 consider the tumor microenvironment.
    Do BT; Vander Heiden MG
    Trends Cancer; 2022 Nov; 8(11):884-886. PubMed ID: 36153305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PDAC metabolism: Environment determines what has GOT2 give.
    Newsom OJ; Sullivan LB
    Cell Metab; 2022 Nov; 34(11):1617-1619. PubMed ID: 36323232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute mitochondrial dysfunction after blast exposure: potential role of mitochondrial glutamate oxaloacetate transaminase.
    Arun P; Abu-Taleb R; Oguntayo S; Wang Y; Valiyaveettil M; Long JB; Nambiar MP
    J Neurotrauma; 2013 Oct; 30(19):1645-51. PubMed ID: 23600763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy.
    van Karnebeek CDM; Ramos RJ; Wen XY; Tarailo-Graovac M; Gleeson JG; Skrypnyk C; Brand-Arzamendi K; Karbassi F; Issa MY; van der Lee R; Drögemöller BI; Koster J; Rousseau J; Campeau PM; Wang Y; Cao F; Li M; Ruiter J; Ciapaite J; Kluijtmans LAJ; Willemsen MAAP; Jans JJ; Ross CJ; Wintjes LT; Rodenburg RJ; Huigen MCDG; Jia Z; Waterham HR; Wasserman WW; Wanders RJA; Verhoeven-Duif NM; Zaki MS; Wevers RA
    Am J Hum Genet; 2019 Sep; 105(3):534-548. PubMed ID: 31422819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner.
    Honorat JA; Nakatsuji Y; Shimizu M; Kinoshita M; Sumi-Akamaru H; Sasaki T; Takata K; Koda T; Namba A; Yamashita K; Sanda E; Sakaguchi M; Kumanogoh A; Shirakura T; Tamura M; Sakoda S; Mochizuki H; Okuno T
    PLoS One; 2017; 12(11):e0187215. PubMed ID: 29107957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma.
    Bai J; Tang R; Zhou K; Chang J; Wang H; Zhang Q; Shi J; Sun C
    BMC Med Genomics; 2022 Oct; 15(1):222. PubMed ID: 36284275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0006220 Contributes to NSCLC Progression through miR-342-3p/GOT2 Axis.
    Tang J; Li X; Zhao L; Hui J; Ding N
    Ann Thorac Cardiovasc Surg; 2023 Feb; 29(1):11-22. PubMed ID: 36575008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity.
    Hickman TL; Choi E; Whiteman KR; Muralidharan S; Pai T; Johnson T; Parikh A; Friedman T; Gilbert M; Shen B; Barron L; McGinness KE; Ettenberg SA; Motz GT; Weiss GJ; Jensen-Smith A
    PLoS One; 2022; 17(5):e0266980. PubMed ID: 35507536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression.
    Feist M; Schwarzfischer P; Heinrich P; Sun X; Kemper J; von Bonin F; Perez-Rubio P; Taruttis F; Rehberg T; Dettmer K; Gronwald W; Reinders J; Engelmann JC; Dudek J; Klapper W; Trümper L; Spang R; Oefner PJ; Kube D
    Nat Commun; 2018 Apr; 9(1):1514. PubMed ID: 29666362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.